Stay updated on Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T06:59:00.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the Record History, and the previous v3.6.6 entry was removed.
    Difference
    0.1%
    Check dated 2026-09-20T01:54:03.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The history now includes a new Revision: v3.6.6 entry, replacing the previous Revision: v3.6.5. This reflects a minor metadata update to the page’s version history on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-08-30T00:42:29.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The history shows a new site revision (v3.6.5) was added and the previous revision (v3.6.4) was removed, reflecting a minor system update.
    Difference
    0.1%
    Check dated 2026-08-08T23:37:43.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    A new version entry, Revision: v3.6.4, appears in the history, replacing the prior Revision: v3.6.3. This reflects a minor update to the record's versioning on the page.
    Difference
    0.1%
    Check dated 2026-07-25T17:12:14.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    A new release entry, Revision: v3.6.3, has been added to the study record's version history, following the previous Revision: v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-04T04:52:50.000Z thumbnail image

Stay in the know with updates to Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.